Physician
Advantagecare Physicians PC
Advantagecare Physicians PC was paid $60.52M by Medicaid between Jan 2018 and Dec 2024, across 190 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoADVANTAGECARE PHYSICIANS PC
NEW YORK, NY 10128
NEW YORK, NY 10128
33aNPI1336578772assigned 11/06/2013
33bProvider typeGeneral Practice Physician
28Total paid$60.52M
24GClaims2,325,288
24DCodes billed190
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in New York
Rank by total paid#1 of 178
Median peer was paid$27K
This provider vs. median2,256×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 215,635 | $5.73M | |
| 2019 | 289,677 | $6.98M | |
| 2020 | 304,713 | $6.52M | |
| 2021 | 376,999 | $9.42M | |
| 2022 | 396,578 | $10.53M | |
| 2023 | 424,914 | $12.29M | |
| 2024incomplete | 316,772 | $9.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 362,399 | 342,477 | $20.80M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 254,592 | 246,897 | $18.10M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.6% | 109,694 | 109,118 | $2.80M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.0% | 45,396 | 45,351 | $2.41M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.5% | 37,564 | 37,530 | $2.14M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 38,143 | 38,050 | $2.10M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 6,278 | 6,271 | $1.17M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.8% | 14,884 | 14,862 | $1.11M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 16,058 | 16,021 | $1.10M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 15,458 | 15,190 | $766K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.2% | 5,157 | 5,154 | $739K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 7,590 | 7,577 | $689K |
178 more codes
| 92551 | <1% | 81,017 | $590K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 6,853 | $522K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14,402 | $494K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,245 | $451K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42,240 | $371K |
| 96127 | <1% | 103,092 | $339K | |
| 90461 | <1% | 16,237 | $336K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 720 | $284K |
| 11721 | <1% | 8,194 | $242K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,007 | $184K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,244 | $126K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,482 | $121K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,079 | $111K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,588 | $111K |
| 00812 | <1% | 528 | $107K | |
| 99385 | <1% | 1,337 | $105K | |
| 93000 | <1% | 8,116 | $104K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 7,281 | $94K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,669 | $93K |
| 92134 | <1% | 2,827 | $87K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 4,232 | $83K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 185 | $77K |
| 92250 | <1% | 1,879 | $73K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,380 | $68K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,143 | $68K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,535 | $65K |
| 99173 | <1% | 79,772 | $62K | |
| 90686 | <1% | 45,628 | $60K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 80,184 | $59K |
| 90682 | <1% | 1,093 | $57K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 15,270 | $55K |
| 92020 | <1% | 2,706 | $54K | |
| 97802 | <1% | 946 | $42K | |
| 76641 | <1% | 386 | $41K | |
| 0012A | <1% | 1,269 | $40K | |
| 99441 | <1% | 1,014 | $39K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 575 | $35K |
| 81025 | <1% | 8,290 | $33K | |
| 97597 | <1% | 651 | $32K | |
| 99442 | <1% | 611 | $31K | |
| 11056 | <1% | 735 | $31K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 53 | $31K |
| 0011A | <1% | 1,118 | $30K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,585 | $29K |
| 76830 | Ultrasound, transvaginal | <1% | 331 | $29K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 987 | $22K |
| 93015 | <1% | 348 | $22K | |
| 99386 | <1% | 246 | $21K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 147 | $21K |
| 99459 | <1% | 864 | $19K | |
| 90651 | <1% | 7,934 | $18K | |
| 90620 | <1% | 2,515 | $18K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 190 | $16K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,171 | $15K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 552 | $15K |
| 76536 | <1% | 169 | $15K | |
| 81003 | <1% | 6,799 | $12K | |
| 83655 | <1% | 1,104 | $11K | |
| 76642 | <1% | 133 | $11K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,013 | $10K |
| 73562 | <1% | 284 | $10K | |
| 99443 | <1% | 116 | $10K | |
| 94060 | <1% | 235 | $10K | |
| 73630 | <1% | 350 | $9K | |
| 92083 | <1% | 165 | $9K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 118 | $9K |
| 0064A | <1% | 402 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 706 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 545 | $8K |
| 20550 | <1% | 190 | $7K | |
| 92133 | <1% | 235 | $7K | |
| 94010 | <1% | 359 | $6K | |
| 90677 | <1% | 1,620 | $6K | |
| 99383 | <1% | 79 | $6K | |
| 90715 | <1% | 930 | $6K | |
| 97014 | <1% | 1,051 | $5K | |
| 76857 | <1% | 151 | $5K | |
| 93224 | <1% | 65 | $5K | |
| 72100 | <1% | 193 | $5K | |
| 29540 | <1% | 442 | $5K | |
| 77080 | <1% | 164 | $5K | |
| 97803 | <1% | 209 | $4K | |
| 85018 | <1% | 2,127 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 46 | $4K |
| 11900 | <1% | 114 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 65 | $4K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 45 | $4K |
| 73030 | <1% | 152 | $4K | |
| 90656 | <1% | 3,106 | $3K | |
| 95117 | <1% | 524 | $3K | |
| 72050 | <1% | 83 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 24 | $3K |
| 1126F | <1% | 271,785 | $3K | |
| 00813 | <1% | 13 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 37 | $2K |
| 92002 | <1% | 39 | $2K | |
| 97010 | <1% | 1,433 | $2K | |
| 99406 | <1% | 452 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 250 | $2K |
| 90673 | <1% | 42 | $2K | |
| 68761 | <1% | 36 | $2K | |
| 90670 | <1% | 10,300 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 12 | $2K |
| 11730 | <1% | 27 | $2K | |
| 3074F | <1% | 6,147 | $2K | |
| 99188 | <1% | 194 | $2K | |
| 87634 | <1% | 138 | $1K | |
| 90746 | <1% | 27 | $1K | |
| 76813 | <1% | 13 | $1K | |
| 73610 | <1% | 42 | $1K | |
| 90688 | <1% | 471 | $1K | |
| 3078F | <1% | 5,329 | $1K | |
| 99051 | <1% | 513 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 99 | $1K |
| 97161 | <1% | 39 | $1K | |
| 73130 | <1% | 37 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $930.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 208 | $913.52 |
| 3079F | <1% | 3,535 | $870.00 | |
| 90633 | <1% | 4,365 | $801.07 | |
| 99384 | <1% | 26 | $785.76 | |
| 92202 | <1% | 63 | $756.01 | |
| 90734 | <1% | 6,279 | $727.12 | |
| 90474 | <1% | 89 | $689.58 | |
| 90710 | <1% | 597 | $643.15 | |
| 86580 | <1% | 86 | $633.87 | |
| 0031A | <1% | 17 | $619.62 | |
| 11100 | <1% | 15 | $608.16 | |
| 97162 | <1% | 25 | $585.61 | |
| 1125F | <1% | 33,594 | $539.84 | |
| 90716 | <1% | 128 | $509.30 | |
| 94726 | <1% | 13 | $508.89 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 76 | $456.80 |
| 95125 | <1% | 69 | $440.57 | |
| 92201 | <1% | 28 | $401.22 | |
| 92225 | <1% | 12 | $388.78 | |
| 99401 | <1% | 571 | $357.12 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 135 | $338.58 |
| 90707 | <1% | 134 | $336.00 | |
| 90723 | <1% | 4,711 | $264.20 | |
| 90744 | <1% | 66 | $218.35 | |
| 92015 | Determination of refractive state | <1% | 2,227 | $187.57 |
| 90647 | <1% | 5,911 | $132.10 | |
| 3077F | <1% | 797 | $122.50 | |
| 97035 | <1% | 19 | $122.40 | |
| 76514 | <1% | 13 | $113.47 | |
| 98925 | <1% | 14 | $102.72 | |
| 36416 | <1% | 5,032 | $89.66 | |
| 90680 | <1% | 3,028 | $89.25 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 260 | $82.72 |
| 1160F | <1% | 4,536 | $65.00 | |
| 94760 | <1% | 364 | $49.11 | |
| 96160 | <1% | 26 | $42.79 | |
| 90648 | <1% | 173 | $35.70 | |
| 82962 | <1% | 25 | $33.75 | |
| 3075F | <1% | 233 | $32.50 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 25 | $32.45 |
| 94150 | <1% | 14 | $30.33 | |
| 3080F | <1% | 42 | $15.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 24 | $14.09 |
| 90662 | <1% | 40 | $12.31 | |
| 3044F | <1% | 78 | $10.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 66 | $7.68 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $1.40 |
| 0502F | 0% | 3,206 | $0.00 | |
| 90685 | 0% | 300 | $0.00 | |
| 90700 | 0% | 70 | $0.00 | |
| 90661 | 0% | 98 | $0.00 | |
| 1159F | 0% | 212 | $0.00 | |
| 1158F | 0% | 69 | $0.00 | |
| 3051F | 0% | 29 | $0.00 | |
| 3008F | 0% | 427,437 | $0.00 | |
| 90696 | 0% | 152 | $0.00 | |
| 1220F | 0% | 311 | $0.00 | |
| 1170F | 0% | 69 | $0.00 | |
| 99381 | 0% | 12 | $0.00 | |
| 90654 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODRIGUEZ, NAVARRA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Siuc Medical PC | Bronx, NY | $1.28M |
| Advantagecare Physicians PC | Staten Island, NY | $146K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.